A1C and coronary artery calcification in nondiabetic men and women

Yoosoo Chang1, Kyung Eun Yun, Hyun-Suk Jung

  • 1Center for Cohort Studies, Total Healthcare Center, Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, Korea.

Insights

Higher hemoglobin A1C (A1C) levels are associated with coronary artery calcification (CAC) in nondiabetic adults. This link between A1C and subclinical atherosclerosis persists even in metabolically healthy individuals.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Public Health

Background:

  • Coronary artery calcification (CAC) is a marker of subclinical atherosclerosis.
  • Hemoglobin A1C (A1C) reflects average blood glucose levels over 2-3 months.
  • The association between A1C and CAC in individuals without diabetes or overt cardiovascular disease is not fully understood.

Purpose of the Study:

  • To investigate the relationship between A1C levels and the presence of CAC.
  • To determine if this association is independent of traditional cardiovascular disease risk factors and fasting glucose levels.
  • To examine this association in a large cohort of nondiabetic Korean adults.

Main Methods:

  • Cross-sectional study of 25,564 Korean adults without diabetes or clinically evident cardiovascular disease.
  • Assessment of CAC using cardiac computed tomography.
  • Measurement of A1C, fasting glucose, and traditional cardiovascular disease risk factors.

Main Results:

  • Coronary artery calcification (CAC) was present in 12.0% of men and 4.9% of women.
  • Higher A1C levels were significantly associated with increased odds of CAC in both men and women, even after adjusting for confounders.
  • The association remained significant even in individuals without metabolic abnormalities, including elevated fasting glucose.

Conclusions:

  • Elevated hemoglobin A1C (A1C) is independently associated with subclinical coronary atherosclerosis (CAC).
  • This association is present even in metabolically healthy individuals without diabetes.
  • A1C may serve as a valuable marker for cardiovascular risk assessment beyond traditional risk factors.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...